nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftizoxime—Injection site burning—Carmustine—melanoma	0.134	0.152	CcSEcCtD
Ceftizoxime—Induration—Bleomycin—melanoma	0.0322	0.0368	CcSEcCtD
Ceftizoxime—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—melanoma	0.0303	0.571	CbGpPWpGaD
Ceftizoxime—Nephropathy toxic—Bleomycin—melanoma	0.0251	0.0286	CcSEcCtD
Ceftizoxime—Nephropathy toxic—Carmustine—melanoma	0.0219	0.025	CcSEcCtD
Ceftizoxime—Tenderness—Bleomycin—melanoma	0.0165	0.0188	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.0156	0.0177	CcSEcCtD
Ceftizoxime—Injection site pain—Carmustine—melanoma	0.0154	0.0176	CcSEcCtD
Ceftizoxime—Eosinophilia—Vemurafenib—melanoma	0.0148	0.0169	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.0132	0.015	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Dactinomycin—melanoma	0.0126	0.0144	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Temozolomide—melanoma	0.0122	0.0139	CcSEcCtD
Ceftizoxime—Phlebitis—Bleomycin—melanoma	0.0121	0.0139	CcSEcCtD
Ceftizoxime—Vaginal infection—Temozolomide—melanoma	0.0115	0.0131	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Temozolomide—melanoma	0.0114	0.013	CcSEcCtD
Ceftizoxime—Phlebitis—Dactinomycin—melanoma	0.0113	0.0129	CcSEcCtD
Ceftizoxime—Erythema multiforme—Vemurafenib—melanoma	0.0113	0.0129	CcSEcCtD
Ceftizoxime—Phlebitis—Carmustine—melanoma	0.0106	0.0121	CcSEcCtD
Ceftizoxime—Ceftibuten—SLC15A2—melanoma	0.0101	0.144	CrCbGaD
Ceftizoxime—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00879	0.01	CcSEcCtD
Ceftizoxime—Pancytopenia—Bleomycin—melanoma	0.00859	0.0098	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Vemurafenib—melanoma	0.00849	0.00968	CcSEcCtD
Ceftizoxime—Cefepime—SLC15A2—melanoma	0.00829	0.119	CrCbGaD
Ceftizoxime—Pancytopenia—Dactinomycin—melanoma	0.00801	0.00914	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00795	0.00907	CcSEcCtD
Ceftizoxime—Neutropenia—Dactinomycin—melanoma	0.00789	0.009	CcSEcCtD
Ceftizoxime—Cefuroxime—SLC15A2—melanoma	0.0075	0.107	CrCbGaD
Ceftizoxime—Pancytopenia—Carmustine—melanoma	0.0075	0.00855	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00746	0.0085	CcSEcCtD
Ceftizoxime—Neutropenia—Carmustine—melanoma	0.00738	0.00842	CcSEcCtD
Ceftizoxime—Haemoglobin—Bleomycin—melanoma	0.00728	0.0083	CcSEcCtD
Ceftizoxime—Pancytopenia—Temozolomide—melanoma	0.00725	0.00826	CcSEcCtD
Ceftizoxime—Haemorrhage—Bleomycin—melanoma	0.00724	0.00826	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Bleomycin—melanoma	0.0072	0.00821	CcSEcCtD
Ceftizoxime—Neutropenia—Temozolomide—melanoma	0.00714	0.00814	CcSEcCtD
Ceftizoxime—Agranulocytosis—Dactinomycin—melanoma	0.00702	0.008	CcSEcCtD
Ceftizoxime—Phlebitis—Docetaxel—melanoma	0.00682	0.00777	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00675	0.00769	CcSEcCtD
Ceftizoxime—Body temperature increased—Vemurafenib—melanoma	0.00671	0.00765	CcSEcCtD
Ceftizoxime—Cefixime—SLC15A2—melanoma	0.00648	0.0929	CrCbGaD
Ceftizoxime—Erythema multiforme—Dactinomycin—melanoma	0.00639	0.00728	CcSEcCtD
Ceftizoxime—Haemoglobin—Carmustine—melanoma	0.00635	0.00724	CcSEcCtD
Ceftizoxime—Haemorrhage—Carmustine—melanoma	0.00632	0.00721	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Carmustine—melanoma	0.00629	0.00717	CcSEcCtD
Ceftizoxime—Hypersensitivity—Vemurafenib—melanoma	0.00626	0.00713	CcSEcCtD
Ceftizoxime—Haemoglobin—Temozolomide—melanoma	0.00614	0.007	CcSEcCtD
Ceftizoxime—Haemorrhage—Temozolomide—melanoma	0.00611	0.00696	CcSEcCtD
Ceftizoxime—Ceftazidime—SLC15A2—melanoma	0.0061	0.0873	CrCbGaD
Ceftizoxime—Hypoaesthesia—Temozolomide—melanoma	0.00608	0.00693	CcSEcCtD
Ceftizoxime—Pruritus—Vemurafenib—melanoma	0.00601	0.00685	CcSEcCtD
Ceftizoxime—Cefdinir—SLC15A2—melanoma	0.00598	0.0857	CrCbGaD
Ceftizoxime—Anaemia—Bleomycin—melanoma	0.00583	0.00664	CcSEcCtD
Ceftizoxime—Diarrhoea—Vemurafenib—melanoma	0.00581	0.00662	CcSEcCtD
Ceftizoxime—Erythema multiforme—Temozolomide—melanoma	0.00578	0.00658	CcSEcCtD
Ceftizoxime—Cefradine—SLC15A2—melanoma	0.00568	0.0814	CrCbGaD
Ceftizoxime—Leukopenia—Bleomycin—melanoma	0.00564	0.00643	CcSEcCtD
Ceftizoxime—Anaemia—Dactinomycin—melanoma	0.00543	0.0062	CcSEcCtD
Ceftizoxime—Vomiting—Vemurafenib—melanoma	0.0054	0.00616	CcSEcCtD
Ceftizoxime—Rash—Vemurafenib—melanoma	0.00535	0.0061	CcSEcCtD
Ceftizoxime—Dermatitis—Vemurafenib—melanoma	0.00535	0.0061	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00529	0.00603	CcSEcCtD
Ceftizoxime—Leukopenia—Dactinomycin—melanoma	0.00526	0.006	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Bleomycin—melanoma	0.00514	0.00587	CcSEcCtD
Ceftizoxime—Anaemia—Carmustine—melanoma	0.00509	0.0058	CcSEcCtD
Ceftizoxime—Nausea—Vemurafenib—melanoma	0.00504	0.00575	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Bleomycin—melanoma	0.00504	0.00574	CcSEcCtD
Ceftizoxime—Leukopenia—Carmustine—melanoma	0.00492	0.00562	CcSEcCtD
Ceftizoxime—Anaemia—Temozolomide—melanoma	0.00491	0.0056	CcSEcCtD
Ceftizoxime—Pancytopenia—Docetaxel—melanoma	0.00482	0.0055	CcSEcCtD
Ceftizoxime—Convulsion—Carmustine—melanoma	0.00477	0.00544	CcSEcCtD
Ceftizoxime—Leukopenia—Temozolomide—melanoma	0.00476	0.00543	CcSEcCtD
Ceftizoxime—Neutropenia—Docetaxel—melanoma	0.00475	0.00541	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Dactinomycin—melanoma	0.0047	0.00536	CcSEcCtD
Ceftizoxime—Cefotaxime—SLC15A2—melanoma	0.00469	0.0672	CrCbGaD
Ceftizoxime—Ceftriaxone—SLC15A2—melanoma	0.00462	0.0662	CrCbGaD
Ceftizoxime—Paraesthesia—Bleomycin—melanoma	0.00462	0.00527	CcSEcCtD
Ceftizoxime—Convulsion—Temozolomide—melanoma	0.00461	0.00525	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00449	0.00511	CcSEcCtD
Ceftizoxime—Pain—Bleomycin—melanoma	0.0044	0.00502	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Carmustine—melanoma	0.0044	0.00501	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Temozolomide—melanoma	0.00434	0.00495	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Temozolomide—melanoma	0.00425	0.00484	CcSEcCtD
Ceftizoxime—Agranulocytosis—Docetaxel—melanoma	0.00422	0.00481	CcSEcCtD
Ceftizoxime—Pain—Dactinomycin—melanoma	0.0041	0.00468	CcSEcCtD
Ceftizoxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—melanoma	0.00409	0.0769	CbGpPWpGaD
Ceftizoxime—Haemoglobin—Docetaxel—melanoma	0.00408	0.00465	CcSEcCtD
Ceftizoxime—Body temperature increased—Bleomycin—melanoma	0.00407	0.00464	CcSEcCtD
Ceftizoxime—Haemorrhage—Docetaxel—melanoma	0.00406	0.00463	CcSEcCtD
Ceftizoxime—Cefalotin—SLC15A2—melanoma	0.00405	0.058	CrCbGaD
Ceftizoxime—Hypoaesthesia—Docetaxel—melanoma	0.00404	0.00461	CcSEcCtD
Ceftizoxime—Paraesthesia—Carmustine—melanoma	0.00403	0.0046	CcSEcCtD
Ceftizoxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC17A5—melanoma	0.00393	0.074	CbGpPWpGaD
Ceftizoxime—Paraesthesia—Temozolomide—melanoma	0.0039	0.00444	CcSEcCtD
Ceftizoxime—Erythema multiforme—Docetaxel—melanoma	0.00384	0.00438	CcSEcCtD
Ceftizoxime—Pain—Carmustine—melanoma	0.00384	0.00438	CcSEcCtD
Ceftizoxime—Body temperature increased—Dactinomycin—melanoma	0.00379	0.00432	CcSEcCtD
Ceftizoxime—Hypersensitivity—Bleomycin—melanoma	0.00379	0.00432	CcSEcCtD
Ceftizoxime—Pain—Temozolomide—melanoma	0.00371	0.00423	CcSEcCtD
Ceftizoxime—Cephalexin—SLC15A2—melanoma	0.00368	0.0527	CrCbGaD
Ceftizoxime—Pruritus—Bleomycin—melanoma	0.00364	0.00415	CcSEcCtD
Ceftizoxime—Body temperature increased—Carmustine—melanoma	0.00355	0.00405	CcSEcCtD
Ceftizoxime—Hypersensitivity—Dactinomycin—melanoma	0.00353	0.00403	CcSEcCtD
Ceftizoxime—Body temperature increased—Temozolomide—melanoma	0.00343	0.00391	CcSEcCtD
Ceftizoxime—Hypersensitivity—Carmustine—melanoma	0.00331	0.00377	CcSEcCtD
Ceftizoxime—Diarrhoea—Dactinomycin—melanoma	0.00328	0.00374	CcSEcCtD
Ceftizoxime—Vomiting—Bleomycin—melanoma	0.00327	0.00373	CcSEcCtD
Ceftizoxime—Anaemia—Docetaxel—melanoma	0.00327	0.00373	CcSEcCtD
Ceftizoxime—Rash—Bleomycin—melanoma	0.00324	0.0037	CcSEcCtD
Ceftizoxime—Dermatitis—Bleomycin—melanoma	0.00324	0.00369	CcSEcCtD
Ceftizoxime—Hypersensitivity—Temozolomide—melanoma	0.0032	0.00365	CcSEcCtD
Ceftizoxime—Leukopenia—Docetaxel—melanoma	0.00317	0.00361	CcSEcCtD
Ceftizoxime—Diarrhoea—Carmustine—melanoma	0.00307	0.0035	CcSEcCtD
Ceftizoxime—Pruritus—Temozolomide—melanoma	0.00307	0.0035	CcSEcCtD
Ceftizoxime—Convulsion—Docetaxel—melanoma	0.00306	0.00349	CcSEcCtD
Ceftizoxime—Nausea—Bleomycin—melanoma	0.00306	0.00348	CcSEcCtD
Ceftizoxime—Vomiting—Dactinomycin—melanoma	0.00305	0.00348	CcSEcCtD
Ceftizoxime—Rash—Dactinomycin—melanoma	0.00303	0.00345	CcSEcCtD
Ceftizoxime—Diarrhoea—Temozolomide—melanoma	0.00297	0.00339	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Docetaxel—melanoma	0.00289	0.00329	CcSEcCtD
Ceftizoxime—Vomiting—Carmustine—melanoma	0.00286	0.00326	CcSEcCtD
Ceftizoxime—Nausea—Dactinomycin—melanoma	0.00285	0.00325	CcSEcCtD
Ceftizoxime—Rash—Carmustine—melanoma	0.00283	0.00323	CcSEcCtD
Ceftizoxime—Dermatitis—Carmustine—melanoma	0.00283	0.00323	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Docetaxel—melanoma	0.00283	0.00322	CcSEcCtD
Ceftizoxime—Vomiting—Temozolomide—melanoma	0.00276	0.00315	CcSEcCtD
Ceftizoxime—Rash—Temozolomide—melanoma	0.00274	0.00312	CcSEcCtD
Ceftizoxime—Dermatitis—Temozolomide—melanoma	0.00273	0.00312	CcSEcCtD
Ceftizoxime—Nausea—Carmustine—melanoma	0.00267	0.00304	CcSEcCtD
Ceftizoxime—Paraesthesia—Docetaxel—melanoma	0.00259	0.00295	CcSEcCtD
Ceftizoxime—Nausea—Temozolomide—melanoma	0.00258	0.00294	CcSEcCtD
Ceftizoxime—Pain—Docetaxel—melanoma	0.00247	0.00281	CcSEcCtD
Ceftizoxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—melanoma	0.00241	0.0453	CbGpPWpGaD
Ceftizoxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.00232	0.0436	CbGpPWpGaD
Ceftizoxime—Body temperature increased—Docetaxel—melanoma	0.00228	0.0026	CcSEcCtD
Ceftizoxime—Hypersensitivity—Docetaxel—melanoma	0.00213	0.00242	CcSEcCtD
Ceftizoxime—Pruritus—Docetaxel—melanoma	0.00204	0.00233	CcSEcCtD
Ceftizoxime—Diarrhoea—Docetaxel—melanoma	0.00197	0.00225	CcSEcCtD
Ceftizoxime—Vomiting—Docetaxel—melanoma	0.00183	0.00209	CcSEcCtD
Ceftizoxime—Rash—Docetaxel—melanoma	0.00182	0.00207	CcSEcCtD
Ceftizoxime—Dermatitis—Docetaxel—melanoma	0.00182	0.00207	CcSEcCtD
Ceftizoxime—Nausea—Docetaxel—melanoma	0.00171	0.00195	CcSEcCtD
Ceftizoxime—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC5A5—melanoma	0.00163	0.0307	CbGpPWpGaD
Ceftizoxime—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.00108	0.0202	CbGpPWpGaD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—ABCB5—melanoma	0.00104	0.0196	CbGpPWpGaD
Ceftizoxime—SLC15A1—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.00104	0.0195	CbGpPWpGaD
Ceftizoxime—Ceftriaxone—ALB—melanoma	0.000994	0.0142	CrCbGaD
Ceftizoxime—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.000962	0.0181	CbGpPWpGaD
Ceftizoxime—SLC15A1—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00094	0.0177	CbGpPWpGaD
Ceftizoxime—Cefalotin—ALB—melanoma	0.000871	0.0125	CrCbGaD
Ceftizoxime—Cephalexin—ALB—melanoma	0.000792	0.0113	CrCbGaD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—ARL2—melanoma	0.000721	0.0136	CbGpPWpGaD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000547	0.0103	CbGpPWpGaD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000526	0.00989	CbGpPWpGaD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000478	0.00898	CbGpPWpGaD
Ceftizoxime—SLC15A1—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.00043	0.00809	CbGpPWpGaD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000218	0.00411	CbGpPWpGaD
Ceftizoxime—SLC15A1—SLC-mediated transmembrane transport—ALB—melanoma	0.000205	0.00386	CbGpPWpGaD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—ABCB1—melanoma	0.000167	0.00313	CbGpPWpGaD
Ceftizoxime—SLC15A1—Transmembrane transport of small molecules—ALB—melanoma	0.000104	0.00196	CbGpPWpGaD
